Attention-deficit/hyperactivity disorder (Q56095090)

attention deficit hyperactivity disorder

Europe PubMed Central

title

Attention-deficit/hyperactivity disorder (English)

0 references

1 reference

1 reference

based on heuristic

inferred from title

author

Josep Antoni Ramos-Quiroga

Josep Antoni Ramos-Quiroga

6

0 references

Barbara Franke

Barbara Franke

10

0 references

Philip Asherson

Philip Asherson

2

0 references

Tobias Banaschewski

3

Tobias Banaschewski

0 references

Joseph Biederman

4

Joseph Biederman

0 references

Stephen Faraone

1

Stephen V. Faraone

0 references

Luis Augusto Rohde

7

Luis Augusto Rohde

0 references

Edmund Sonuga-Barke

8

Edmund J. S. Sonuga-Barke

0 references

Jan Buitelaar

5

Jan K. Buitelaar

0 references

author name string

Rosemary Tannock

Nature Reviews Disease Primers

9

0 references

language of work or name

English

0 references

publication date

6 August 2015

0 references

published in

0 references

volume

1

0 references

issue

1

1 reference

https://scigraph.springernature.com/pub.10.1038/nrdp.2015.20

12 September 2019

page(s)

15020

0 references

exact match

0 references

cites work

The Earliest Reference to ADHD in the Medical Literature? Melchior Adam Weikard's Description in 1775 of "Attention Deficit" (Mangel der Aufmerksamkeit, Attentio Volubilis)

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Epidemiological modelling of attention-deficit/hyperactivity disorder and conduct disorder for the Global Burden of Disease Study 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Evaluating the evidence for and against the overdiagnosis of ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Prevalence of attention-deficit hyperactivity disorder in older adults in The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Old people reporting childhood AD/HD symptoms: retrospectively self-rated AD/HD symptoms in a population-based Swedish sample aged 65-80.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

ADHD in DSM-5: a field trial in a large, representative sample of 18- to 19-year-old adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Family income in early childhood and subsequent attention deficit/hyperactivity disorder: a quasi-experimental study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Factors associated with attention deficit/hyperactivity disorder among US children: results from a national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Prevalence of psychiatric disorders among children of different ethnic origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

The heritability of clinically diagnosed attention deficit hyperactivity disorder across the lifespan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

The genetics of attention deficit/hyperactivity disorder in adults, a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Molecular genetics of attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Quantitative and molecular genetics of ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Rethinking environmental contributions to child and adolescent psychopathology: A meta-analysis of shared environmental influences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Childhood attention-deficit hyperactivity disorder as an extreme of a continuous trait: a quantitative genetic study of 8,500 twin pairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Developmental twin study of attention problems: high heritabilities throughout development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Genetic and environmental influences on adult attention deficit hyperactivity disorder symptoms: a large Swedish population-based study of twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Genetic associations between the symptoms of attention-deficit/hyperactivity disorder and emotional lability in child and adolescent twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Deficient emotional self-regulation and adult attention deficit hyperactivity disorder: a family risk analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Co-transmission of conduct problems with attention-deficit/hyperactivity disorder: familial evidence for a distinct disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

The separation of ADHD inattention and hyperactivity-impulsivity symptoms: pathways from genetic effects to cognitive impairments and symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Genetic overlap between measures of hyperactivity/inattention and mood in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Familial links between attention deficit hyperactivity disorder, conduct disorder, and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Genetic risk for attention-deficit/hyperactivity disorder contributes to neurodevelopmental traits in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

High loading of polygenic risk for ADHD in children with comorbid aggression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Shared polygenic contribution between childhood attention-deficit hyperactivity disorder and adult schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Candidate gene studies of ADHD: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Candidate genetic pathways for attention-deficit/hyperactivity disorder (ADHD) show association to hyperactive/impulsive symptoms in children with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Integrated genome-wide association study findings: identification of a neurodevelopmental network for attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Familial confounding of the association between maternal smoking during pregnancy and ADHD in offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Biological and rearing mother influences on child ADHD symptoms: revisiting the developmental interface between nature and nurture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Inattention/overactivity following early severe institutional deprivation: presentation and associations in early adolescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Environmental risk factors for attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Biomarkers and attention-deficit/hyperactivity disorder: a systematic review and meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

A comparison of molecular alterations in environmental and genetic rat models of ADHD: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Prenatal nicotine exposure mouse model showing hyperactivity, reduced cingulate cortex volume, reduced dopamine turnover, and responsiveness to oral methylphenidate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Rodent models of attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

The serotonin transporter gene polymorphism 5-HTTLPR moderates the effects of stress on attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Pre- and peri-natal environmental risks for attention-deficit hyperactivity disorder (ADHD): the potential role of epigenetic processes in mediating susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Modeling attention-deficit/hyperactivity disorder: a critical appraisal of the cognitive-energetic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Neuroeconomics of attention-deficit/hyperactivity disorder: differential influences of medial, dorsal, and ventral prefrontal brain networks on suboptimal decision making?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Identifying the neurobiology of altered reinforcement sensitivity in ADHD: a review and research agenda

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Time perception: modality and duration effects in attention-deficit/hyperactivity disorder (ADHD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

How Can the Comorbidity with ADHD Aid Understanding of Language and Speech Disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Intraindividual variability in ADHD and its implications for research of causal links

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Distinct neuropsychological subgroups in typically developing youth inform heterogeneity in children with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Undertreatment of Motor Problems in Children with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

A comprehensive assessment of memory, delay aversion, timing, inhibition, decision making and variability in attention deficit hyperactivity disorder: advancing beyond the three-pathway models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Toward systems neuroscience of ADHD: a meta-analysis of 55 fMRI studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Ventral-striatal responsiveness during reward anticipation in ADHD and its relation to trait impulsivity in the healthy population: a meta-analytic review of the fMRI literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Is there evidence for neural compensation in attention deficit hyperactivity disorder? A review of the functional neuroimaging literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Effects of stimulants on brain function in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Meta-analysis of Functional Magnetic Resonance Imaging Studies of Inhibition and Attention in Attention-deficit/Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Connecting the dots: a review of resting connectivity MRI studies in attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Developmentally stable whole-brain volume reductions and developmentally sensitive caudate and putamen volume alterations in those with attention-deficit/hyperactivity disorder and their unaffected siblings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Current self-reported symptoms of attention deficit/hyperactivity disorder are associated with total brain volume in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Functional topography in the human cerebellum: a meta-analysis of neuroimaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Meta-analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Diffusion tensor imaging in attention deficit/hyperactivity disorder: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Mapping the development of the basal ganglia in children with attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Development of cortical surface area and gyrification in attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Dopamine and cognitive control: the influence of spontaneous eyeblink rate and dopamine gene polymorphisms on perseveration and distractibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Cortical thinning of the attention and executive function networks in adults with attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Thalamo-cortical activation and connectivity during response preparation in adults with persistent and remitted ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Brain differences between persistent and remitted attention deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Trajectories of cerebral cortical development in childhood and adolescence and adult attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Reduced right frontal cortical thickness in children, adolescents and adults with ADHD and its correlation to clinical variables: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Brain cortical thickness in ADHD: age, sex, and clinical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Neurobiology of attention-deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Towards conceptualizing a neural systems-based anatomy of attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Causal models of attention-deficit/hyperactivity disorder: from common simple deficits to multiple developmental pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Separation of cognitive impairments in attention-deficit/hyperactivity disorder into 2 familial factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Deficient emotional self-regulation and pediatric attention deficit hyperactivity disorder: a family risk analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Systematic review of national and international guidelines on attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Attention deficit hyperactivity disorder in African American children: what can be concluded from the past ten years?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Children should be seen and heard: self-report of feelings and behaviors in primary-school-age children with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Parent-based diagnosis of attention deficit disorder predicts a diagnosis based on teacher report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

How Informative Are Parent Reports of Attention-Deficit/Hyperactivity Disorder Symptoms for Assessing Outcome in Clinical Trials of Long-Acting Treatments? A Pooled Analysis of Parents' and Teachers' Reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Do parental reports of child hyperkinetic disorder symptoms at school predict teacher ratings?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

The impact of case definition on attention-deficit/hyperactivity disorder prevalence estimates in community-based samples of school-aged children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Diagnostic instability of DSM-IV ADHD subtypes: effects of informant source, instrumentation, and methods for combining symptom reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Clinical practice. Attention deficit-hyperactivity disorder in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Six years ahead: a longitudinal analysis regarding course and predictive value of the Strengths and Difficulties Questionnaire (SDQ) in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Healthy body, healthy mind?: the effectiveness of physical activity to treat ADHD in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Gender effects on attention-deficit/hyperactivity disorder in adults, revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Attention-deficit/hyperactivity disorder in adults: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Psychometric properties of an adult ADHD diagnostic interview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Validity of pilot Adult ADHD Self- Report Scale (ASRS) to Rate Adult ADHD symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Is adult attention deficit hyperactivity disorder a valid diagnosis in the presence of high IQ?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Stability of executive function deficits into young adult years: a prospective longitudinal follow-up study of grown up males with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

What is to be the fate of ADHD subtypes? An introduction to the special section on research on the ADHD subtypes and implications for the DSM-V.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Attention-Deficit Hyperactivity Disorder in Girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Childhood trajectories of inattention and hyperactivity and prediction of educational attainment in early adulthood: a 16-year longitudinal population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

The comorbidity of ADHD and autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Does ADHD predict substance-use disorders? A 10-year follow-up study of young adults with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

The lifetime impact of attention deficit hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Causal Heterogeneity in Attention-Deficit/Hyperactivity Disorder: Do We Need Neuropsychologically Impaired Subtypes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Multiple deficits in ADHD: executive dysfunction, delay aversion, reaction time variability, and emotional deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Cognitive training for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

How does psychoeducation help? A review of the effects of providing information about Tourette syndrome and attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Parental preferences and goals regarding ADHD treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

NICE guideline: attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: a review of controlled and naturalistic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Does long-term medication use improve the academic outcomes of youth with attention-deficit/hyperactivity disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

To stop or not to stop? How long should medication treatment of attention-deficit hyperactivity disorder be extended?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Toward quality care in ADHD: defining the goals of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Lisdexamfetamine dimesylate: linear dose-proportionality, low intersubject and intrasubject variability, and safety in an open-label single-dose pharmacokinetic study in healthy adult volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Melatonin Treatment for Insomnia in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Comparison of the pharmacokinetics and clinical efficacy of new extended-release formulations of methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Cardiovascular safety of stimulants in children with attention-deficit/hyperactivity disorder: a nationwide prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

ADHD drugs and serious cardiovascular events in children and young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

American Academy of Pediatrics/American Heart Association clarification of statement on cardiovascular evaluation and monitoring of children and adolescents with heart disease receiving medications for ADHD: May 16, 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Cardiac risk assessment before the use of stimulant medications in children and youth: A joint position statement by the Canadian Paediatric Society, the Canadian Cardiovascular Society, and the Canadian Academy of Child and Adolescent Psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

A meta-analysis of the consistency of atomoxetine treatment effects in pediatric patients with attention-deficit/hyperactivity disorder from 15 clinical trials across four geographic regions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Long-term, open-label extension study of guanfacine extended release in children and adolescents with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Guanfacine extended release: a novel treatment for attention-deficit/hyperactivity disorder in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

A systematic review of combination therapy with stimulants and atomoxetine for attention-deficit/hyperactivity disorder, including patient characteristics, treatment strategies, effectiveness, and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

A systematic review of randomized controlled trials of bupropion versus methylphenidate in the treatment of attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Stimulant treatment of ADHD and cigarette smoking: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Stimulant ADHD medication and risk for substance abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Misuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Tourette Syndrome and comorbid ADHD: current pharmacological treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Bupropion for adults with attention-deficit hyperactivity disorder: meta-analysis of randomized, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Psychopharmacology and aggression. I: A meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Symptoms of attention-deficit/hyperactivity disorder following traumatic brain injury in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Reading outcomes of children and adolescents with attention-deficit/hyperactivity disorder and dyslexia following atomoxetine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Atomoxetine and stroop task performance in adult attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Patterns and predictors of adolescent academic achievement and performance in a sample of children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Pharmacologic intervention for attention-deficit hyperactivity disorder in preschoolers : is it justified?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Nonpharmacological Interventions for ADHD: Systematic Review and Meta-Analyses of Randomized Controlled Trials of Dietary and Psychological Treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Towards an evidence-based taxonomy of nonpharmacologic treatments for ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Research review: the role of diet in the treatment of attention-deficit/hyperactivity disorder--an appraisal of the evidence on efficacy and recommendations on the design of future studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Restriction and elimination diets in ADHD treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Behavior management for school-aged children with ADHD

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Middle school-based and high school-based interventions for adolescents with ADHD

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

ADHD: Non-Pharmacologic Interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Behavioral interventions in attention-deficit/hyperactivity disorder: a meta-analysis of randomized controlled trials across multiple outcome domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

21 January 2018

Social skills training.

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Remediating organizational functioning in children with ADHD: immediate and long-term effects from a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

School-based interventions for elementary school students with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Cognitive behavioral therapy for adolescents with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Current status of cognitive behavioral therapy for adult attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Neuropsychologically informed strategic psychotherapy in teenagers and adults with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Family therapy for adolescents with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Efficacy of Neurofeedback Treatment in ADHD: The Effects on Inattention, Impulsivity and Hyperactivity: A Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Neurofeedback for ADHD: a review of current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Computer-based cognitive training for ADHD: a review of current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Computerized training of working memory in children with ADHD--a randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Substance use disorders in adolescents with attention deficit hyperactivity disorder: a 4-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Medication for attention deficit-hyperactivity disorder and criminality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Adult attention-deficit hyperactivity disorder and obesity: epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Attention deficit hyperactivity disorder and suicide: a review of possible associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Does childhood attention-deficit/hyperactivity disorder predict risk-taking and medical illnesses in adulthood?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

The quality of life of children with attention deficit/hyperactivity disorder: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Comparison of the burden of illness for adults with ADHD across seven countries: a qualitative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Daily life impairments associated with childhood/adolescent attention-deficit/hyperactivity disorder as recalled by adults: results from the European Lifetime Impairment Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

The impact of medications on quality of life in attention-deficit hyperactivity disorder: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Modifiers of long-term school outcomes for children with attention-deficit/hyperactivity disorder: does treatment with stimulant medication make a difference? Results from a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Common etiological factors of attention-deficit/hyperactivity disorder and suicidal behavior: a population-based study in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Methylphenidate and the risk of trauma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Academic achievement and emotional status of children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Grand challenges in global mental health

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Genetics of complex traits in psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Toward developmental models of psychiatric disorders in zebrafish

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Modelling schizophrenia using human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Developing constructs for psychopathology research: research domain criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Biomarkers for attention-deficit/hyperactivity disorder (ADHD). A consensus report of the WFSBP task force on biological markers and the World Federation of ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Extreme learning machine-based classification of ADHD using brain structural MRI data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Reduced GABA concentration in attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Serotonin platelet-transporter measures in childhood attention-deficit/hyperactivity disorder (ADHD): clinical versus experimental measures of impulsivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Can sodium/hydrogen exchange inhibitors be repositioned for treating attention deficit hyperactivity disorder? An in silico approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Review of medication adherence in children and adults with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Pros and cons of pragmatic clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Predictors of persistence in girls with attention deficit hyperactivity disorder: results from an 11-year controlled follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

The Child Attention-Deficit Hyperactivity Disorder Teacher Telephone Interview (CHATTI): reliability and validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Drugs for attention deficit–hyperactivity disorder do not increase the mid-term risk of sudden death in children: A meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Parenting and family stress treatment outcomes in attention deficit hyperactivity disorder (ADHD): an empirical analysis in the MTA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

The worldwide prevalence of ADHD: a systematic review and metaregression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Educational and occupational underattainment in adults with attention-deficit/hyperactivity disorder: a controlled study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Is maternal smoking during pregnancy a risk factor for attention deficit hyperactivity disorder in children?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Temporal reward discounting and ADHD: task and symptom specific effects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Magnetic Resonance Imaging of Boys With Attention-Deficit/Hyperactivity Disorder and Their Unaffected Siblings

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

White matter microstructure and developmental improvement of hyperactive/impulsive symptoms in attention-deficit/hyperactivity disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Effectiveness of a teacher-based indicated prevention program for preschool children with externalizing problem behavior

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Population pharmacodynamic modeling of various extended-release formulations of methylphenidate in children with attention deficit hyperactivity disorder via meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

ADHD: prevalence, diagnosis, and issues of comorbidity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Combined pharmacotherapy: an emerging trend in pediatric psychopharmacology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Young adult outcome of hyperactive children: adaptive functioning in major life activities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Atomoxetine treatment in children and adolescents with attention-deficit hyperactivity disorder: what are the long-term health-related quality-of-life outcomes?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

ADHD-associated dopamine transporter, latrophilin and neurofibromin share a dopamine-related locomotor signature in Drosophila

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

Effects of stimulant medication on neuropsychological functioning in young adults with attention-deficit/hyperactivity disorder.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20

inferred from DOI database lookup

7 January 2021

based on heuristic

The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.20